Endrina, Alphamer .

HRN: 27-05-46  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/05/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
05/05/2025
05/11/2025
IV
200mg
Q6h
Sepsis
Waiting Final Action 

Indication:  Culture-directedEmpirical Escalation    Type of Infection:  Bloodstream    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: